<p>(1) Novel Stem Cell Strategies with mTOR<br>Kenneth Maiese</p> <p>(2) mTOR: The master regulator of conceptus development in response to uterine histotroph during pregnancy in ungulates<br>Xiaoqiu Wang, Guoyao Wu and Fuller W. Bazer</p> <p>(3) mTORC1 in the control of myogenesis and adult skeletal muscle mass<br>Marita A. Wallace, David C. Hughes, and Keith Baar</p> <p>(4) mTOR: A Critical Mediator of Articular Cartilage Homeostasis<br>Akihiro Nakamura and Mohit Kapoor</p> <p>(5) The Role of mTOR, Autophagy, Apoptosis and Oxidative Stress during Toxic Metal Injury<br>Sarmishtha Chatterjee, Chayan Munshi, and Shelley Bhattacharya</p> <p><br>Section II. mTOR in Genetic Disorders and Neurodegenerative Disease</p> <p>(6) The mTOR signaling pathway in neurodegenerative diseases<br>Arnaud FRANCOIS, Julie VERITE, Agnès RIOUX BILAN, Thierry JANET, Frédéric CALON, Bernard FAUCONNEAU, Marc PACCALIN, and Guylène PAGE</p> <p>(7) mTOR: Exploring a new potential therapeutic target for stroke<br>Mar Castellanos, Carme Gubern, and Elisabet Kadar </p> <p>(8) mTOR signalling in epilepsy and epileptogenesis: preclinical and clinical studies<br>Antonio Leo, Andrew Constanti, Antonietta Coppola, Rita Citraro, Giovambattista De Sarro, and Emilio Russo</p> <p>(9) mTOR, Autophagy, Aminoacidopathies and Human Genetic Disorders<br>Garrett R. Ainslie, K. Michael Gibson, and Kara R. Vogel</p> <p><br>Section III. mTOR in Memory, Behavior, and Aging</p> <p>(10) mTOR involvement in the mechanisms of memory: an overview of animal studies<br>Maria Grazia Giovannini and Daniele Lana</p> <p>(11) Mammalian Target of Rapamycin (mTOR), Aging, Neuroscience And Their Association With Aging-Related Diseases<br>Ergul Dilan Celebi Birand, Elif Tugce Karoglu, Fusun Doldur Balli, and Michelle Adams</p> <p>(12) The role of mTOR in mood disorders pathophysiology and treatment<br>Gislaine Z. Réus, Meagan R. Pitcher, Camila O. Arent, and João Quevedo</p> <p>(13) mTOR and Drugs of Abuse<br>Jacob T. Beckley and Dorit Ron</p> <p><br>Section IV. mTOR in Cardiovascular Development and Disease </p> <p>(14) mTOR as a modulator of metabolite sensing relevant to angiogenesis<br>Soumya S.J., Athira A.P., Binu S. and Sudhakaran P. R</p> <p>(15) Role of mTOR Signaling in Cardioprotection<br>Anindita Das and Rakesh C Kukreja</p> <p>(16) Role of Mammalian Target of Rapamycin (mTOR) in Cardiac Homeostasis in Metabolic Disorders<br>Xiangwei Liu and Jun Ren</p> <p><br>Section V. mTOR in the Immune System and Autoimmune Disorders</p> <p>(17) Roles of Mechanistic Target of Rapamycin in the Adaptive and Innate Immune Systems<br>Hiroshi Kato and Andras Perl </p> <p>(18) The Role of mTOR Inhibitors in Solid Organ Transplantation<br>Greg J. McKenna and Goran B.G Klintmalm</p> <p>(19) mTOR and neuroinflammation<br>Filipe Palavra, António Francisco Ambrósio, and Flávio Reis</p> <p>(20) Novel Molecular targets in Multiple Sclerosis: the emerging role of mTOR in the regulation of glial biology<br>Cinzia Dello Russo, Pierluigi Navarra, and Lucia Lisi </p> <p><br>Section VI. mTOR in the Endocrine System and Disorders of Metabolism</p> <p>(21) mTOR in metabolic and endocrine disorders<br>Marta M. Swierczynska and Michael N. Hall</p> <p>(22) Chronic mTOR inhibition by rapamycin and diabetes: What is the role of mitochondria?<br>Liang-Jun Yan and Zhiyou Cai</p> <p>(23) mTOR in diabetic nephropathy and retinopathy<br>Rosa Fernandes and Flávio Reis</p> <p><br>Section VII. mTOR and Cancer</p> <p>(24) Lymphangioleiomyomatosis (LAM): Molecular Insights into mTOR Regulation Lead to Targeted Therapies <br>Wendy K. Steagall, Connie G. Glasgow, Gustavo Pacheco-Rodriguez, and Joel Moss</p> <p>(25) mTOR PATHWAY IN RENAL CELL CARCINOMA<br>Matteo Santoni and Francesco Massari</p> <p>(26) Metabolic Shunt Pathways, Carcinoma, and mTOR<br>Norisuke Shibuya, Ken-ichi Inoue, and Keiichi Kubota</p>
